Table 4.
Prevalence of different antibodies among APS patients with a history of thrombosis only, pregnancy morbidity only, or both.
| Thrombosis only (N=90) | Pregnancy morbidity only (N=70) | Both (N=15) | p1 a | p2 | p3 | |
|---|---|---|---|---|---|---|
| aCL, n (%) | 19 (21.1) | 9 (12.9) | 1 (6.7) | 0.173 | 0.683b | 0.293b |
| aβ2 GPI, n (%) | 45 (50.0) | 14 (20.0) | 3 (20.0) | 0.000* | 1.000b | 0.048b,* |
| LA, n (%) | 59 (65.6) | 31 (44.3) | 6 (40.0) | 0.007* | 0.761a | 0.059a |
| aAnnexinV, n (%) | 52 (57.8) | 41 (58.6) | 10 (66.7) | 0.920 | 0.561a | 0.517a |
| aPE, n (%) | 36 (40.0) | 18 (25.7) | 3 (20.0) | 0.058 | 0.753b | 0.161b |
| aPS/PT, n (%) | 51 (56.7) | 22 (31.4) | 6 (40.0) | 0.001* | 0.522a | 0.230a |
| aPS IgG, n (%) | 45 (50.0) | 22 (31.4) | 4 (26.7) | 0.015* | 1.000b | 0.156b |
| aPS IgM, n (%) | 15 (16.7) | 12 (17.1) | 2 (13.3) | 0.936 | 1.000b | 1.000b |
| APhL IgG, n (%) | 45 (50.0) | 19 (27.1) | 4 (26.7) | 0.003* | 1.000b | 0.161b |
| APhL IgM, n (%) | 16 (17.8) | 18 (25.7) | 1 (6.7) | 0.223 | 0.172b | 0.456b |
p1, p-values refer to Thrombosis vs. Pregnancy morbidity; p2, p-values refer to Both vs. Pregnancy morbidity; p3, p-values refer to Thrombosis vs. Both. aPearson Chi-square test; bFisher’s exact test. *p < 0.05.